ADMA Biologics, Inc. (ADMA)
9.385
+0.04
(+0.48%)
USD |
NASDAQ |
Aug 31, 16:00
9.385
0.00 (0.00%)
After-Hours: 16:34
ADMA Biologics Cash from Operations (Annual) : 50.40M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 50.40M |
| December 31, 2024 | 118.67M |
| December 31, 2023 | 8.80M |
| December 31, 2022 | -59.51M |
| December 31, 2021 | -112.37M |
| December 31, 2020 | -102.00M |
| December 31, 2019 | -76.19M |
| December 31, 2018 | -62.68M |
| Date | Value |
|---|---|
| December 31, 2017 | -37.27M |
| December 31, 2016 | -18.27M |
| December 31, 2015 | -15.42M |
| December 31, 2014 | -14.70M |
| December 31, 2013 | -10.89M |
| December 31, 2012 | -6.904M |
| December 31, 2011 | -1.431M |
| December 31, 2010 | -4.813M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Erasca, Inc. | -95.46M |
| Krystal Biotech, Inc. | 200.86M |
| Vericel Corp. | 51.91M |
| Emergent BioSolutions, Inc. | 170.60M |
| Exelixis, Inc. | 884.27M |